Customs and Border Patrol’s Flu Vaccine Policy Breaches Basic Public Health Tenet

The U.S. Customs and Border Patrol’s decision to withhold vaccinations against seasonal influenza from migrants in border detention facilities is a violation of the most basic principles of public health and human rights.

Antibiotics Report Highlights Stewardship, Workforce, Research Needs

A CDC report on antibiotics use in health care U.S. healthcare settings show progress made in promoting appropriate use of infection-fighting drugs, but strengthened and continued efforts needed.

Journal Supplement Provides Valuable Resource to Support Diversity in the Field of ID

A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA).

Public Comment Period for IDSA/AAN/ACR Draft Lyme Disease Guidelines Extended through Sept. 9

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have extended the public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease for an additional 30 days.

Increased CMS Reimbursements for New Antibiotics Represents Progress in Attention to AMR

The Centers for Medicare and Medicaid Services Inpatient Prospective Payment System rule for the coming fiscal year will raise reimbursements for novel antibiotics, a meaningful step in confronting the threat of infections resistant to older medicines.

HIV Status Has No Place in Border Patrol Policy

IDSA, HIVMA, SHEA and PIDS call for humane, evidenced-based border policies that reflect the science and adhere to ID prevention and treatment protocols.

Declaration of PHEIC in DRC Should Spur Support, Not Fear

The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region.

IDSA Congratulates 23 Institutions on Centers of Excellence Designation

IDSA has awarded 23 institutions the designation of Antimicrobial Stewardship Centers of Excellence (CoE).

AMR Crisis Demands Immediate Action, IDSA Treasurer Tells Legislators

IDSA Board Member Dr. Helen Boucher, FIDSA, described AMR challenges, solutions to members of the House Oversight and Reform National Security subcommittee in June 26 testimony, urging lawmakers to incentivize development of new antibiotics and protect existing ones.

Public Comment Period for IDSA/AAN/ACR Draft Lyme Disease Guidelines Open

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have opened a public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease.

Reauthorization of PAHPA Builds Foundation for Public Health Readiness

The reauthorization of the Pandemic and All Hazards Preparedness Act signed by the president Monday includes measures that are critical to ensure that our nation has the resources and expertise needed to confront, control and combat emerging public health threats.

House FY 2020 Appropriations Respond to Most Infectious Disease and HIV Realities

With increased funds for important federal programs and interventions responding to infectious diseases and HIV, the health, foreign operations, and defense spending bill for fiscal year 2020 passed by the House of Representatives Wednesday reflects an understanding of a broad scope of public health threats at home and around the world, and of the resources needed to address them.